gprc5d and fcrh5 targeted therapies in myeloma
Published 1 year ago • 1K plays • Length 1:02:21
Download video MP4
Download video MP3
Similar videos
-
2:14
going beyond bcma-targeting agents in myeloma: gprc5d and fcrh5-targeting therapies
-
1:47
a new target for car-t therapy in myeloma - gprc5d | fredrik schjesvold, md | ash 2021
-
4:53
bcma and gprc5d targeted therapy | luciano costa, md, phd | ash 2023
-
0:41
fcrh5 & gprc5d bispecific antibodies: antigen targets beyond bcma for multiple myeloma
-
1:10
the importance of bcma, fcrh5 and gprc5d in multiple myeloma
-
5:21
beyond bcma: gprc5d & fcrh5
-
57:49
know your myeloma therapy: what's available for maintenance therapy?
-
56:40
immunotherapy 101 for multiple myeloma patients
-
0:42
how can gprc5d and fcrh5 therapies benefit my myeloma treatment?
-
1:00
multiple myeloma life expectancy
-
7:44
the future of myeloma drug development | dickran kazandjian, md
-
7:40
results of bispecific antibody combination in advanced myeloma | yael cohen, md | asco 2023
-
1:24
bispecifics & cars: bcma, gprc5d & fcrh5 sequencing
-
15:05
overview of healthtree programs for multiple myeloma
-
0:53
what is multiple myeloma?
-
0:44
how advances in multiple myeloma research are extending lives
-
3:46
understanding myeloma therapy targets bcma and gprc5d
-
2:43
why gprc5d is a promising target for multiple myeloma
-
26:09
integrative medicine: ideas for myeloma treatment - richard lee, md | rt irvine, ca nov 5, 2022
Clip.africa.com - Privacy-policy